Anvisa Approves New Semaglutide Pens, Including the 1st Generic
12 Articles
12 Articles
CartaCapital
EBCSubstance became known as the active principle of the ozempic
Freepik The National Agency for Sanitary Surveillance (Anvisa) approved the registration of new medicines based on semaglutide, from the Brazilian laboratories EMS and Germed. The active principle is used in items of the class of GLP-1 analogues, popularly known as weight-loss pens. The resolution is from the last Thursday (13), but was published in the Official Journal of the Union (DOU) of this second (17). The products were registered in the …
The National Agency for Health Surveillance (Anvisa) approved the registration of new medicines based on semaglutide produced by Brazilian laboratories. The Official Journal of the Union published the decision on Monday, 17th, contemplating products from EMS and Germed. EMS was authorized to market the generic version of the active principle. Already Germed obtained the registration of Semaclique, a similar medicine. The two products follow the …
The health authority authorized the use of the daily pill Wegovy® tablets, capable of reducing up to 17% of body weight and providing cardiovascular protection in adult patients. By: Drafting MEXICO CITY, August 17, 2026.- The Federal Commission for the Protection against Health Risks (COFEPRIS) gave green light to the marketing of 25 mg oral semaglutide (Wegovy® tablets), developed by the pharmaceutical Novo Nordisk, making Mexico the first cou…
Mexico became the first Latin American country to approve the oral semagglutide of 25 milligrams of Novo Nordisk , which is marketed under the name of Wegovy, for weight management, so that the pharmaceutical company adds a tablet alternative to its portfolio of treatments against obesity. The authorization of the Federal Commission for the Protection against Health Risks (Cofepris) allows the use of the medication in obese adults and overweight…
The National Agency of Health Surveillance (Anvisa) authorized on Monday, 17, the registration of the first generic medicine based on semaglutide in Brazil. Produced by EMS, Ozivy is intended for the treatment of type 2 diabetes and, in specific concentrations, for weight control.Semaglutide is the active principle of Ozempic, a reference medicine used in the treatment of type 2 diabetes.In higher doses, the substance is also used in weight cont…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
